Skip to main content
. 2003 Mar 26;138(6):1129–1139. doi: 10.1038/sj.bjp.0705085

Table 4.

Efficacy parameters

Ligand enantiomer DPAT 5-OH DPAT 6-OH DPAT 7-OH DPAT 8-OH DPAT
  R S R S R S R S R S
Kl/Kh 98.0 25.1 22.2 33.5 29.9 11.7 57.4 17.7 126.1 48.4
Kl/EC50 11.3 5.4 3.2 2.0 6.7 1.2 6.2 1.8 10.7 2.0

Kl/Kh and Kl/EC50 ratios were determined from the data in Tables 1, 2 and 3 as described in the text. Kl was defined using competition versus [3H]-NAD-199, and Kh was derived from the mean of the pKh and pKi values derived in competition versus [3H]-NAD-199 and [3H]-8-OH DPAT, respectively.